Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
		
    Lymphotoxin β receptor signalling executes Helicobacter pylori-driven gastric inflammation in a T4SS-dependent manner.
        
        Gut 66, 1369-1381 (2016)
    
    
    
				Objective Lymphotoxin ß receptor (LTßR) signalling has been implicated in inflammation-associated tumour development in different tissues. We have analysed the role of LTßR and alternative NF-κB signalling in Helicobacter pylori-mediated gastric inflammation and pathology. Design We analysed several ligands and receptors of the alternative NF-κB pathway, RelB, p52 nuclear translocation and target genes in tissue samples of H. pylori-infected patients with different degrees of gastritis or early gastric tumours by in situ hybridisation, immunohistochemistry, Western blot and real-time PCR analyses. Molecular mechanisms involved in LTßR activation by H. pylori were assessed in vitro using human gastric cancer cell lines and distinct H. pylori isolates. The effects of blocking or agonistically activating LTßR on gastric pathology during challenge with a human pathogenic H. pylori strain were studied in a mouse model. Results Among the tested candidates, LT was significantly increased and activated alternative NF-κB signalling was observed in the gastric mucosa of H. pylori-infected patients. H. pylori induced LTßR-ligand expression in a type IV secretion system-dependent but CagA-independent manner, resulting in activation of the alternative NF-κB pathway, which was further enhanced by blocking canonical NF-κB during infection. Blocking LTßR signalling in vivo suppressed H. pylori-driven gastritis, whereas LTßR activation in gastric epithelial cells of infected mice induced a broadened pro-inflammatory chemokine milieu, resulting in exacerbated pathology. Conclusions LTßR-triggered activation of alternative NF- κB signalling in gastric epithelial cells executes H. pyloriinduced chronic gastritis, representing a novel target to restrict gastric inflammation and pathology elicited by H. pylori, while exclusively targeting canonical NF-κB may aggravate pathology by enhancing the alternative pathway.
			
			
		Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Times Cited
Scopus
Cited By
					
					Cited By
Altmetric
					
				14.921
					3.862
					19
					22
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
     
    
    
        Schlagwörter
        Epithelial Cells ; Helicobacter Pylori - Gastritis ; Helicobacter Pylori - Pathogenesis; Nf-kappa-b; Epithelial-cells; Alternative Pathway; Lymphoid Follicles; Virulence Factors; Nf-kappa-b2 P100; Prostate-cancer; Gene-expression; Activation; Kinase
    
 
     
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2016
    
 
     
    
        HGF-Berichtsjahr
        2016
    
 
    
    
        ISSN (print) / ISBN
        0017-5749
    
 
    
        e-ISSN
        1468-3288
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        Gut (eGut)
    
 
		
    
        Quellenangaben
        
	    Band: 66,  
	    Heft: 8,  
	    Seiten: 1369-1381 
	    
	    
	
    
 
  
         
        
            Verlag
            BMJ Publishing Group
        
 
        
            Verlagsort
            London
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30201 - Metabolic Health
 
    30201 - Metabolic Health
        Forschungsfeld(er)
        Immune Response and Infection
Genetics and Epidemiology
 
    Genetics and Epidemiology
        PSP-Element(e)
        G-551600-001
G-500600-001
 
     
     	
    G-500600-001
        PubMed ID
        27196595
    
    
    
        WOS ID
        WOS:000405191200006
    
    
        Scopus ID
        84965022086
    
    
        Erfassungsdatum
        2016-05-19